BPC-157 may be less appropriate for those with a history of cancer or active malignancy, individuals uncomfortable with the investigational nature of peptide therapy, people unable to commit to consistent daily administration for 4-8 weeks, those seeking instant results rather than gradual healing, and anyone who cannot source pharmaceutical-grade products from reputable suppliers
What Each GHK-Cu Dosage Level Actually Produces: Skin, Hair, and Healing Outcomes GHK-Cu acts as a systemic repair signal, not a targeted treatment for one area
PMID: 11718984
What signaling pathways are most often cited for BPC-157
BPC-157 Peptide Nasal Spray may help by interacting with key molecules in the body that control inflammation
The most common complaints include mild injection site irritation, temporary fatigue, or slight changes in appetite